http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111419820-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1617 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 |
| filingDate | 2020-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-111419820-B |
| titleOfInvention | Desloratadine citrate disodium capsule and preparation method and application thereof |
| abstract | The invention provides a desloratadine citrate disodium capsule and a preparation method and application thereof. The capsule consists of desloratadine citrate disodium particles and an empty capsule, wherein the desloratadine citrate disodium particles contain desloratadine citrate disodium, ascorbic acid, a filling agent, a lubricating agent and an adhesive, and the weight percentages of the desloratadine citrate disodium particles to the capsule are respectively (5-12) to (1-3) to (80-150) to (0.5-2) to (0.5-3). The invention also provides a preparation method of the desloratadine citrate disodium capsule and application of the desloratadine citrate disodium capsule in preparing medicaments for treating rhinitis and urticaria. The desloratadine citrate disodium capsule has a reasonable formula and a simple and convenient production process; the dissolution rate and stability of the desloratadine citrate disodium capsule are remarkably improved by adding the ascorbic acid component. |
| priorityDate | 2020-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 79.